Pipeline Accelerator 2024-25 Round 2 Outcomes
Therapeutic Innovation Australia (TIA), in partnership with Phenomics Australia, Bioplatforms Australia and ANSTO’s National Deuteration Facility, is thrilled to announce the successful recipients of the Pipeline Accelerator 2024-25 (Round 2). Enabled by the National Collaborative Research Infrastructure Strategy (NCRIS), all four NCRIS providers mentioned above are working together to help address the medical products challenge outlined in the […]
200+ Reasons to Celebrate: TIA Launches Pipeline Accelerator Casebook
TIA is proud to announce the publication of our Pipeline Accelerator Casebook, a celebration of seven years of supporting therapeutic development across Australia through the Pipeline Accelerator scheme, a competitive funding initiative that helps academic researchers and SMEs access the facilities and expertise they need to progress promising health and medical innovations. The casebook brings together more than just individual stories […]
Major Investment for Psychiatric Drug Development
Co-founders Dr Greg Stewart, Associate Professor Jess Nithianantharajah and Professor Chris Langmead TIA’s Pipeline Accelerator Helps Phrenix Therapeutics Secure Major Investment for Psychiatric Drug Development Phrenix Therapeutics, a biotech company developing next-generation medicines for psychiatric and neurological disorders, has secured seed investment from Curie.Bio (US) and Brandon Capital (Australia). Therapeutic Innovation Australia (TIA) is proud to […]
Pipeline Accelerator Voucher Recipients Announced
Therapeutic Innovation Australia (TIA), in partnership with Phenomics Australia and the National Deuteration Facility (NDF), is thrilled to announce the successful recipients of the Pipeline Accelerator 2024-25 (Round 1). Supported through the National Collaborative Research Infrastructure Strategy (NCRIS), this initiative helps address the medical products challenge outlined in the 2021 National Research Infrastructure (NRI) Roadmap. […]
Therapeutic Innovation Australia and Phenomics Australia partnership reinforces commitment to address the medical products challenge
In partnership with Phenomics Australia (PA), Therapeutic Innovation Australia (TIA) is pleased to announce the successful recipients of the Pipeline Accelerator 2023-24 (Round 2). Through the National Collaborative Research Infrastructure Strategy (NCRIS) program, TIA and PA support a network of national research infrastructure to address the medical products challenge in the 2021 National Research Infrastructure […]
